PL BioScience announces Strengthening of Management Team Appointment of Oliver Dick as new Chief Technology Officer PL BioScience announced the strengthening of its management team with the appointment of Oliver Dick, PhD. Oliver Dick joins the team as Chief Technology Officer, a strategic position as the company
First Artificial Human Platelet Lysate PL BioScience Raises the Bar in Cell Culture Technology with artificial HPL PL BioScience develops worldwide first artificial Human Platelet Lysate (HPL) solution, and thus a key ingredient for the research & production of cell-based pharmaceuticals. In partnership with the Korean biotech
We are thrilled to unveil our latest innovation: ELAREM™ Ultimate-FD PLUS The gamma irradiated Human Platelet Lysate ELAREM™ Ultimate-FD PLUS is designed to meet the needs of cell manufacturing applications requiring proven viral reduction. As a xeno-free cell culture supplement, ELAREM™ Ultimate-FD PLUS supports the safe and
For all research and cell therapy approaches, cell expansion and thus cell culture media are used and needed. During the last decades (starting in the 1950s) animal serum was the “Gold Standard” for cell expansion because of its high growth factor content and universal use. Cell
We are thrilled to be able to offer the Stem Cell Network NRW the chance to visit our company in Aachen on 16 March 2022. Most of our employees at PL BioScience are scientists or have a scientific background. Therefore, we comprehend very well how difficult it
Why are Mesenchymal Stem Cells so interesting for industry and clinical research? The properties of Mesenchymal Stem Cells (MSCs) make them capable to be used for a broad application in research fields and the development of cell therapies. One topic is getting more important and looked
Why Human Platelet Lysate outperforms Human Serum for Stem Cell Therapy "Which media should I choose for my application?" - There is no short answer because it depends on the application aim of the cell therapy, the production process and sometimes on the cell types and
PL BioScience at the German Biotech Days 2021 Only one month to go until the next opportunity to meet us in person will start: “Die Deutschen Biotechnologietage 2021” (The German Biotech Days 2021) from 20. to 21. September 2021 at the International Congress center Stuttgart. We are
'Accelerating research and discovery' – Human Platelet Lysate in North America 'Accelerating research and discovery'. The mission of the team at Captivate Bio perfectly fits our mission: Providing one solution for all development stages – Human Platelet Lysate. From the beginning, we saw strong synergies between our companies.
PL BioScience starts up complementary workspace at Medace The Aachen-based biotechnology company PL BioScience was founded in 2015 as a spin-off of the RWTH Aachen University, with the idea of delivering animal component-free cell culture supplements. PL BioScience has developed an advanced nutrient solution for
PL BioScience raises € 3.7 mln from Born2Grow, Brightlands Venture Partners, TechVision Fund I and more The capital will be used to expand R&D, increase sales capacity and scale up in-house production PL BioScience produces a human-based nutrient medium for growing cells, as replacement for animal-derived
World Earth Day 2021: Environmental Impact of HPL vs. FBS What do HPL and FBS have to do with the Earth Day 2021? The Earth Day raises awareness and educates people about a more sustainable living. For us, this means we educate about a more sustainable cell
Today is world cancer day A great opportunity to raise awareness for cancer patients and survivors as well as for cancer research and therapies. Cancer is one of the most serious diseases causing almost one in six deaths globally, which is estimated to equal 9.6 million
Animal experiments are one of the most discussed topics in research and in our society. We neither want to condemn animal experiments nor do we want to trivialize this topic. What we want is to raise awareness and open a fact-based discussion about it. Animal experiments are
ELAREM™ Prime is the worldwide first affordable cell culture supplement based on human platelets offering the same benefits as FBS – in an animal serum-free environment. What is ELAREM™ Prime? It is derived from reused transfusion-approved platelets. These platelets can no longer be used for blood transfusions,
Introducing our new human Platelet Lysate brand name: ELAREM™ As a university spin-off, we started manufacturing our human Platelet Lysates (hPL) back in 2015, as ‘PL Solution’ products. For more than five years, you may know our human Platelet Lysates under this name. It is time
A new publication from Kouroupis et al. published in CYTOTHERAPY in July 2020 found out that infrapatellar fat pad (IFP)-mesenchymal stem cells (MSCs) manufactured with human Platelet Lysate (hPL) show enhanced immunomodulatory properties. Findings have potential for a minimally invasive cell therapy for joint disease The authors even
It is a pleasure for us to announce that BORN2GROW GmbH & Co. KG, a subsidiary of Zukunftsfonds Heilbronn (ZFHN), invests in our company and technology. Since almost 20 years the ZFHN successfully consults and accompanies start-up technologies and companies. BORN2GROW is the second investor in
Read in the press article from the "Aachener Zeitung" why human Platelet Lysate is still unusual but morally inoffensive PL BioScience produces human Platelet Lysate (hPL) as a cell culture supplement. This is still unusual because using the controversial Fetal Bovine Serum (FBS) for cell culture
The study performed with human Platelet Lysate (hPL) at the University of Miami showed an enhanced performance of manufactured IFP - MSCs under regulatory compliant conditions. The aim of the study was to proof the hypothesis: IFP-MSCs manufactured under these conditions do not need "ex-vivo priming
